1. Home
  2. SELF vs INKT Comparison

SELF vs INKT Comparison

Compare SELF & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Self Storage Inc.

SELF

Global Self Storage Inc.

N/A

Current Price

$4.88

Market Cap

56.0M

Sector

Real Estate

ML Signal

N/A

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

N/A

Current Price

$8.53

Market Cap

53.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SELF
INKT
Founded
1983
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.0M
53.7M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
SELF
INKT
Price
$4.88
$8.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$6.15
★ $44.00
AVG Volume (30 Days)
★ 19.1K
10.2K
Earning Date
11-06-2026
11-11-2026
Dividend Yield
★ 5.98%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.15
N/A
Revenue
★ $12,705,245.00
N/A
Revenue This Year
$1.53
N/A
Revenue Next Year
$1.22
N/A
P/E Ratio
$32.37
★ N/A
Revenue Growth
★ 1.40
N/A
52 Week Low
$4.74
$8.48
52 Week High
$5.75
$15.27

Technical Indicators

Market Signals
Indicator
SELF
INKT
Relative Strength Index (RSI) 45.79 33.82
Support Level $4.80 N/A
Resistance Level $5.26 $11.92
Average True Range (ATR) 0.09 0.73
MACD 0.01 -0.12
Stochastic Oscillator 40.12 10.85

Price Performance

Historical Comparison
SELF
INKT

About SELF Global Self Storage Inc.

Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.

Share on Social Networks: